Multicenter Trial Management Unit Expands the Scope of Research at Yale
In the past, Yale investigators who led multicenter trials had to put together ad hoc study teams, relying on unconnected siloed services to carry out their research. At the end of these trials, these teams, which had compiled so much experience and knowledge, disbanded and their knowledge was lost. This system was inefficient and put Yale at a disadvantage when competing with other institutions for grants for multicenter studies.
Yale study: Social media boosts friendship quality in adolescents with autism spectrum disorder
A study by Yale Department of Psychiatry and Yale Child Study Center researchers found that adolescents with autism spectrum disorder (ASD) derive high friendship quality through their use of social media
Major autism study underway-Yale researchers leading the charge
A study that could transform the way autism is diagnosed, tracked and treated and the work is being done in New Haven. Yale researchers are leading the charge in the four year study – the largest autism study funded by National Institutes of Health.
Yale School of Medicine and FDA’s Office of Minority Health and Health Equity Diversity Day: "Patient Centered Approach to Care and Research" on Feb. 28
The Innovation and Diversity Summit will focus on raising awareness about the need for minorities and subpopulation participation in clinical trials; patient-centered approaches to care and research; and the role of technology in both areas.
YCCI Scholar Awards: Letters of Intent Due on Jan. 13
We are pleased to announce a request for applications for YCCI Scholar Awards, which provide salary and/or research funds to a select number of junior faculty members who are strongly committed to careers in clinical research, community-based research or translational research.
Yale Launches Comprehensive DNA Sequencing Project, With Aim of Predicting, Preventing, and Treating Gene-related Diseases
Generations, a collaboration between Yale School of Medicine and Yale New Haven Health System, is one of the largest DNA sequencing projects of its kind in the United States.
Research from Yale Vascular Surgeons among Top Papers of Journal of Vascular Surgery
Aortobifemoral bypass is the preferred method of bilateral inflow revascularization, with axillobifemoral bypass reserved for high-risk patients. Hybrid surgery in the form of femorofemoral bypass and retrograde endovascular aortoiliac intervention is increasingly being used to achieve the same goal. This study compared the perioperative outcomes of hybrid surgery with traditional surgery for bilateral inflow revascularization.
Point-of-care Ultrasound's Global Potential
Yale School of Medicine (YSM) faculty, residents, and students are engaged with point-of-care ultrasound (POCUS) initiatives far from the Yale campus, such as in Chile, the Dominican Republic, Rwanda, and Uganda. With its portability and immediacy, POCUS is a powerful diagnostic tool, which also can enhance medical education, both on campus, and worldwide.
Minimizing blood vessel blockage
All cardiac procedures carry a risk of stroke because plaque or calcium buildup can break off in small pieces, ﬂoat up into the brain, and block narrow blood vessels. A highly specialized tool called an embolic protection device is currently used to prevent some of the released debris from reaching the brain.
Coleman Is Named to Federal Committee That Advises on Human Research Protections
Linda Coleman, JD, the director of the Yale Human Research Protection Program, which assists the university in meeting its ethical and regulatory obligations for the protection of human participants in research, has accepted an appointment to the Secretary’s Advisory Committee on Human Research Protection, which advises and makes recommendations to the Secretary of Health and Human Services.
Yale-developed Scorecard Promotes Better Clinical Trial Data Sharing
A tool developed by researchers at Yale, Stanford, and Bioethics International can promote greater sharing of clinical trial data by pharmaceutical companies. While nearly one-third of the companies that the researchers assessed met standards for sharing data, others could be more transparent to the benefit of science and the public, the researchers said.
Department of Neurology Receives Major Grant to Evaluate Blood Thinners and Stroke Prevention
Yale School of Medicine has received a 5-year, $20 million grant from the National Institute of Neurological Disorders and Stroke (NINDS) to administer a Phase III trial measuring the effectiveness of using a blood thinner to prevent new strokes in patients who suffered brain hemorrhages and have atrial fibrillation, or irregular heartbeat.